COMMUNIQUÉS West-GlobeNewswire
-
Curium Announces First Commercial Doses of Diagnostic Radiopharmaceutical in Czech Republic and Slovakia for Patients with Prostate Cancer
19/11/2025 -
GUERBET : Calendrier financier de l’exercice 2026
19/11/2025 -
GUERBET : Financial agenda for 2026
19/11/2025 -
Teva Launches Rise: A Global Open Innovation Platform to Accelerate AI, Industry 4.0, Smart Manufacturing, Digital Health and Biotech Breakthroughs for Pharma’s Biggest Challenges
19/11/2025 -
Protara Therapeutics Announces Positive Interim Results Demonstrating Robust Responses in the Ongoing Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations
19/11/2025 -
Nudj Health and Corewell Health Announce Ground-Breaking New Cost and Utilization Data Highlighting Significant Cost-Savings of its Whole-Person Care Model
19/11/2025 -
Cadrenal Therapeutics CEO, Quang X. Pham, Receives BioFlorida’s Executive of the Year Award
19/11/2025 -
Ascentage Pharma to Participate in Three Upcoming Investor Conferences in December 2025
19/11/2025 -
DeepView™ System Featured at 2025 US Burn Conferences
19/11/2025 -
Alignment Healthcare to Present at Piper Sandler 37th Annual Healthcare Conference
19/11/2025 -
Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer
19/11/2025 -
Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on December 9
19/11/2025 -
ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET.
19/11/2025 -
Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™
19/11/2025 -
HCW Biologics Enters into $4.0 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
19/11/2025 -
TG Therapeutics Makes 2025 Deloitte Technology Fast 500™ List of America’s Fastest-Growing Companies
19/11/2025 -
Precise Bio Achieves World’s First 3D-Bio-Printed Corneal Implant
19/11/2025 -
Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call
19/11/2025 -
Odyssey Health, Inc. Secures Multi-Million-Dollar, Nine-Year Service Contract and Financing Facility for Up to $25 Million
19/11/2025
Pages